Rivaroxaban Laboratory Monitoring in Switzerland 2: Therapeutic Dose (RivaMoS 2)
Clinical trial NCT01710267 · COMPLETED
Trial details
- NCT number
- NCT01710267
- Sponsor
- Prof. Dr. Dr. med. Walter A. Wuillemin, MD, PhD
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.